Ductus venosus

From WikiMD's WELLNESSPEDIA

(Redirected from Patent ductus venosus)

Ductus venosus is a small vein in the fetus that diverts some blood flow away from the liver and sends it directly to the heart. It forms a part of the fetal circulation system and is essential for proper development and growth of the fetus.

Anatomy[edit]

The ductus venosus is located within the umbilical cord and is connected to the umbilical vein, which carries oxygenated blood from the placenta to the fetus. The other end of the ductus venosus is connected to the inferior vena cava, which carries deoxygenated blood back to the heart.

Function[edit]

The primary function of the ductus venosus is to bypass the liver, which is not fully functional in the fetus. This allows the oxygenated blood from the placenta to be delivered directly to the heart, where it can be distributed to the rest of the body. The ductus venosus also plays a role in regulating the volume of blood that flows to the liver.

Closure[edit]

After birth, the ductus venosus closes and becomes a ligament known as the ligamentum venosum. This process is triggered by the increase in blood oxygen levels that occurs when the baby begins to breathe on its own. If the ductus venosus fails to close properly, it can lead to a condition known as patent ductus venosus.

Clinical significance[edit]

A patent ductus venosus can cause a variety of health problems, including heart failure, liver disease, and pulmonary hypertension. Treatment typically involves surgical closure of the ductus venosus.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.